Delta-type opioid receptor
G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
Database | Links |
---|---|
UniProt | P33533 |
PDB | Not available |
BioGrid | Not available |
BindingDB | P33533 |
DrugBank | Not available |
Guide to PHARMACOLOGY | 317 |
PharmGKB | Not available |
KEGG | rno:24613 |
BioCyc | Not available |
Entrez Gene (GeneID) | 24613 |
Metric | Mean Value | Standard Deviation |
---|---|---|
AUC | 0.9815 | 8.8437 × 10-4 |
Accuracy | 0.9465 | 0.002 |
Sensitivity | 0.9478 | 0.0034 |
Specificity | 0.9453 | 0.003 |
BEDROC | 0.9935 | 0.0029 |
MCC Threshold | 0.468 | N/A |
MCC | 0.8957 | N/A |
F-score Threshold | 0.468 | N/A |
F-score | 0.9465 | N/A |